Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient

MeSH terms

• Anaphylaxis / etiology
• Anaphylaxis / prevention & control
• Anti-Allergic Agents / therapeutic use*
• Antibodies, Anti-Idiotypic
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Female
• Heart Arrest / etiology
• Humans
• Hypersensitivity, Immediate / immunology
• Mastocytosis, Systemic / complications
• Mastocytosis, Systemic / drug therapy*
• Mastocytosis, Systemic / physiopathology
• Middle Aged
• Omalizumab